Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1106.3%
operating margin TTM
-1084.38%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.94 |
| peg ratio | 0.00 |
| price to book ratio | 3.22 |
| price to sales ratio | 44.89 |
| enterprise value multiple | -6.06 |
| price fair value | 3.22 |
profitability ratios | |
|---|---|
| gross profit margin | 79.44% |
| operating profit margin | -1084.38% |
| pretax profit margin | -1106.22% |
| net profit margin | -1106.3% |
| return on assets | -36.9% |
| return on equity | -94.9% |
| return on capital employed | -39.65% |
liquidity ratios | |
|---|---|
| current ratio | 10.18 |
| quick ratio | 9.98 |
| cash ratio | 9.12 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 913.39 |
| operating cycle | 958.45 |
| days of payables outstanding | 999.27 |
| cash conversion cycle | -40.81 |
| receivables turnover | 8.10 |
| payables turnover | 0.37 |
| inventory turnover | 0.40 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.29 |
| debt equity ratio | 0.46 |
| long term debt to capitalization | 0.31 |
| total debt to capitalization | 0.31 |
| interest coverage | -11.10 |
| cash flow to debt ratio | -1.20 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.58 |
| cash per share | 1.85 |
| operating cash flow per share | -0.74 |
| free cash flow operating cash flow ratio | 0.79 |
| cash flow coverage ratios | -1.20 |
| short term coverage ratios | -126.67 |
| capital expenditure coverage ratio | -4.74 |
Frequently Asked Questions
When was the last time X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) reported earnings?
X4 Pharmaceuticals, Inc. (XFOR) published its most recent earnings results on 06-05-2026.
What is X4 Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. X4 Pharmaceuticals, Inc. (NASDAQ:XFOR)'s trailing twelve months ROE is -94.9%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. X4 Pharmaceuticals, Inc. (XFOR) currently has a ROA of -36.9%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did XFOR's net profit margin stand at?
XFOR reported a profit margin of -1106.3% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is XFOR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.18 in the most recent quarter. The quick ratio stood at 9.98, with a Debt/Eq ratio of 0.46.